Post-earnings recap
Reported
Thu, Apr 24, 2014
Est. EPS
—
Est. revenue
—
Implied move
—
EPS beat rate
100%
—
Est. EPS
—
Est. Rev
—
Impl. Move
—
Quest Diagnostics reported an EPS of $0.84, which was below expectations, leading to a 1.34% decline in stock price. The lack of revenue data and management commentary may have contributed to investor uncertainty. Overall, the results suggest challenges in meeting market expectations.
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $0.84 | N/A | -5.51% |
| Revenue | N/A | N/A | N/A |
No transcript is on record, and the analysis is based on numerical results only.